Sixty percent of cholangiocarcinomas revealed TROP2 promoter hypermethylation and TROP2 knockdown significantly enhanced the proliferation and migration of cholangiocarcinoma cell lines (44). The gene discussed is TACSTD2; the disease is cholangiocarcinoma.